CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
February 2019—NxGen MDx introduced its NxGen MDx Hereditary Cancer Panel, which tests for variants in 32 genes known to cause certain forms of hereditary cancer. The test includes genes known to affect lifetime risk for breast, ovarian, colon, pancreatic, prostate, uterine, gastric, and melanoma cancers. Patients who order the panel will receive a personalized breast cancer risk assessment that is based on a combination of their test results, reported family history, and personal health history.
NxGen MDx, 855-776-9436
Tagged with: NxGen MDx